First Time Loading...
A

Antares Pharma Inc
NASDAQ:ATRS

Watchlist Manager
Antares Pharma Inc
NASDAQ:ATRS
Watchlist
Price: 5.59 USD Market Closed
Updated: May 5, 2024

Antares Pharma Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Antares Pharma Inc
Cash from Financing Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
A
Antares Pharma Inc
NASDAQ:ATRS
Cash from Financing Activities
-$20m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Financing Activities
-$21.4B
CAGR 3-Years
-46%
CAGR 5-Years
-3%
CAGR 10-Years
-10%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Financing Activities
$8.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Cash from Financing Activities
$26.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Cash from Financing Activities
-$4.8B
CAGR 3-Years
-12%
CAGR 5-Years
17%
CAGR 10-Years
-5%
Eli Lilly and Co
NYSE:LLY
Cash from Financing Activities
$2.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Antares Pharma Inc's Cash from Financing Activities?
Cash from Financing Activities
-20m USD

Based on the financial report for Dec 31, 2021, Antares Pharma Inc's Cash from Financing Activities amounts to -20m USD.